WIRB-Copernicus Group Growth, Revenue, Number of Employees and Funding
Estimated Revenue & Financials
- WIRB-Copernicus Group's estimated revenue is currently $45M per year.
- WIRB-Copernicus Group's estimated revenue per employee is $166667
- WIRB-Copernicus Group has 270 Employees.
- WIRB-Copernicus Group grew their employee count by 13% last year.
- WIRB-Copernicus Group currently has 66 job openings.
|Manuela Zosulis||Director, Talent Acquisition|
|Eric Dintzis||Senior Director of Testing|
|Craig Sowell||Chief Marketing Officer|
|Russ Titsch||Business Development Director Market Intelligence and Insights|
|Kristen Minogue||Director, Learning and Professional Development|
|Erick Green||Director, Business Development|
|Marco Capasso||Chief Legal Officer|
|Joseph Mumma||Vice President, Quality Assurance, Technology-CSO|
|Brooke Millman||Vice President, Consulting Solutions, Site Contracts & Payments|
|Kristi Wood||Vice President Strategic Initiatives and Continuous Improvement|
What Is WIRB-Copernicus Group?
WCG is the world's largest and most trusted provider of regulatory and ethical review services for human research. The pioneer of independent ethical review, WCG continues to drive ingenuity in the clinical research space. Today, WCG's solutions are built upon the foundation of ethical review, but have grown to include a suite of complementary services and technologies that expand the capabilities of the modern research professional. WCG delivers transformational solutions that stimulate growth, foster compliance, and maximize efficiency for those who perform clinical trials. WCG is proud to serve the individuals on the frontlines of science and medicine, and the organizations that strive to develop new products and therapies to improve the quality of human health. It is our role to empower them to accelerate advancement, while ensuring that the risks of progress never outweigh the value of human life. For more information, please visit www.wcgclinical.com.keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Trio, An FCB He...||$7.8M||40||-2%|
|PRI Healthcare ...||$11.5M||56||-5%|
|TAIHO ONCOLOGY ...||$35.8M||194||9%|
|LEO Pharma Inc....||$42.4M||232||3%|
WIRB-Copernicus Group News
PE-backed WIRB-Copernicus Group, which offers compliance- and eClinical-related services to drive efficiency in the clinical trial process, ...
PRINCETON, N.J., Aug. 27, 2019 /PRNewswire/ -- The WIRB-Copernicus Group®'s (WCG™) Clinical Services Division introduces Velos ...
One of scale to watch is pharma services company WIRB-Copernicus Group. Read my story to learn who WCG's backers, Arsenal Capital and ...
WIRB-Copernicus Group Funding
WIRB-Copernicus Group Executive Hires
|2019-01-31||Norman Goldfarb||Chief Collaboration Officer||Article|
WIRB-Copernicus Group Acquisitions
|2016-03-10||Clintrax Global, Inc.||Article|
|2018-07-26||KMR Group, Inc.||Article|
|2019-01-31||Model Agreements & Guidelines International||Article|